Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Gruber

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
International Journal of Molecular Sciences|March 29, 2023
Functional and Phenotypic Characterisations of Common Syngeneic Tumour Cell Lines as Estrogen Receptor-Positive Breast Cancer ModelsMaria Lambouras, Charlotte Roelofs, Melrine Pereira, et al.
Cancer Discovery|January 13, 2021
Serine Biosynthesis Is a Metabolic Vulnerability in FLT3-ITD-Driven Acute Myeloid LeukemiaStefan Bjelosevic, Emily Gruber, Andrea Newbold, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2023
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphomaDanielle H Oh, Xiao Ma, Simon J Hogg, et al.
EMBO Molecular Medicine|May 6, 2022
Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemiaJoan So, Alexander C Lewis, Lorey K Smith, et al.
Cell Reports|August 17, 2022
Inhibition of mutant IDH1 promotes cycling of acute myeloid leukemia stem cellsEmily Gruber, Joan So, Alexander C Lewis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2020
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid TumorsLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Molecular Cancer Therapeutics|November 4, 2025
Discovery and characterisation of VPRBP/DCAF1 kinase inhibitor analogues as microtubular destabilising agents with potent anti-myeloma activityOlivia Susanto, Emily Gruber, Cheng Mun Wun, et al.
Leukemia|April 23, 2022
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphomaJonathan Wong, Emily Gruber, Belinda Maher, et al.
Elife|December 2, 2020
RNF41 regulates the damage recognition receptor Clec9A and antigen cross-presentation in mouse dendritic cellsKirsteen M Tullett, Peck Szee Tan, Hae-Young Park, et al.
Cell|November 20, 2025
Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemiaAlexander C Lewis, Emily Gruber, Rheana Franich, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of Molecular Sciences|March 29, 2023
Functional and Phenotypic Characterisations of Common Syngeneic Tumour Cell Lines as Estrogen Receptor-Positive Breast Cancer ModelsMaria Lambouras, Charlotte Roelofs, Melrine Pereira, et al.
Cancer Discovery|January 13, 2021
Serine Biosynthesis Is a Metabolic Vulnerability in FLT3-ITD-Driven Acute Myeloid LeukemiaStefan Bjelosevic, Emily Gruber, Andrea Newbold, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2023
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphomaDanielle H Oh, Xiao Ma, Simon J Hogg, et al.
EMBO Molecular Medicine|May 6, 2022
Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemiaJoan So, Alexander C Lewis, Lorey K Smith, et al.
Cell Reports|August 17, 2022
Inhibition of mutant IDH1 promotes cycling of acute myeloid leukemia stem cellsEmily Gruber, Joan So, Alexander C Lewis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2020
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid TumorsLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Molecular Cancer Therapeutics|November 4, 2025
Discovery and characterisation of VPRBP/DCAF1 kinase inhibitor analogues as microtubular destabilising agents with potent anti-myeloma activityOlivia Susanto, Emily Gruber, Cheng Mun Wun, et al.
Leukemia|April 23, 2022
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphomaJonathan Wong, Emily Gruber, Belinda Maher, et al.
Elife|December 2, 2020
RNF41 regulates the damage recognition receptor Clec9A and antigen cross-presentation in mouse dendritic cellsKirsteen M Tullett, Peck Szee Tan, Hae-Young Park, et al.
Cell|November 20, 2025
Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemiaAlexander C Lewis, Emily Gruber, Rheana Franich, et al.
Pageof 2